logo
Over 25 lakh deaths averted worldwide due to COVID-19 vaccinations, study estimates

Over 25 lakh deaths averted worldwide due to COVID-19 vaccinations, study estimates

Time of India26-07-2025
New Delhi: COVID-19 vaccines helped prevent more than 25 lakh deaths across the world between 2020 and 2024 -- for every 5,400 doses administered, one death was averted, estimates a study.
Findings published in The Journal of the American Medical Association (JAMA) Health Forum "clearly demonstrate a major overall benefit from COVID-19 vaccination during the years 2020-2024", with 90 per cent of the life-saving benefits secured for the world's older adults.
Researchers from the Catholic University of Milan, Italy, and US' Stanford University analysed publicly available data on worldwide population to estimate number of people who died due to COVID-19 and whether they died before or after getting vaccinated.
"We compared this data with the estimated data modelled in the absence of COVID-19 vaccination and were then able to calculate the numbers of people who were saved by COVID-19 vaccines and the years of life gained as a result of them," author Angelo Maria Pezzullo, researcher in general and applied hygiene, Catholic University of Milan, said.
The team also found that the 82 per cent of the
lives saved by vaccines
involved people getting the shots before encountering the virus, 57 per cent during the Omicron period, and 90 per cent of the lives saved involved people aged 60 years and older.
COVID-19 vaccinations
also helped save 14.8 million years of life -- a year of life saved for every 900 vaccine shots administered, the researchers said.
Further, about three-quarters of the years of life saved were related to people aged 60 and above.
"Before ours, several studies tried to estimate lives saved by vaccines with different models and in different periods or parts of the world," author Stefania Boccia, professor of general and applied hygiene at the Catholic University of Milan, said.
However, "this one is the most comprehensive because it is based on worldwide data, it also covers the Omicron period, it also calculates the number of years of life that was saved, and it is based on fewer assumptions about the pandemic trend," Boccia said.
The authors wrote, "In the main analysis, more than 2.5 million deaths were averted (one death averted per 5,400 vaccine doses administered). Eighty-two percent were among people vaccinated before any infection, 57 per cent were during the Omicron period, and 90 per cent pertained to people 60 years or older."
In an invited commentary article, published in JAMA Health Forum, Monica Gandhi from the University of California San Francisco's Center for AIDS Research writes, "Vaccines save lives and the only way to get through this pandemic was always immunity; it is much safer to provide immunity to an older person through a vaccine than through natural infection."
Gandhi added that in the prospect of a future pandemic, models such as the one used and presented in the study could help mitigate the damage caused by widely restrictive policies, yet allow protection for those needing it the most.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WHO Advises Against The Use Of Antibiotics For COVID-19 Patients
WHO Advises Against The Use Of Antibiotics For COVID-19 Patients

NDTV

timean hour ago

  • NDTV

WHO Advises Against The Use Of Antibiotics For COVID-19 Patients

New Delhi: The World Health Organisation (WHO) has advised against the use of antibiotics even in patients with severe COVID when a concurrent bacterial infection is not suspected. The global health body has released updated recommendations for the clinical management of people with COVID, which, it said, are based on evidence generated from a recent meta-analysis of outcomes of patients treated with antibiotics for the virus. "For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics. For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics," the WHO said. The WHO said that, as COVID-19 epidemiology and severity have changed, and as emergency measures have subsided, the evidence behind a number of recommendations has changed. In parallel, the evolution of health systems and the global environment has meant that the recommendations are implemented in a very different context in 2024 compared to 2020. These guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic, the WHO said. "Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems. "This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19," the WHO said. The new recommendations on the use of antibiotics were prompted by the publication of data from a systematic review and meta-analysis, and the pressing need to address antimicrobial resistance. The WHO said the updated guidelines are for people directly or indirectly involved in the health care of patients with COVID-19 and post-COVID-19 conditions. This includes clinicians, allied health care workers, facility managers, and hospital administrators. The SARS-CoV-2 continues to infect several thousand people daily, leading to preventable morbidity and mortality across the world, the WHO said. The roll-out of vaccines and treatment for COVID-19, and increasing population immunity from infection, has substantially reduced hospitalization, severity of disease, and mortality. "However, the virus continues to evolve in terms of infectivity, immune escape, and disease severity. This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19," the WHO stated.

Can you take antibiotics for COVID? WHO updates its guidelines on antibiotic usage for patients
Can you take antibiotics for COVID? WHO updates its guidelines on antibiotic usage for patients

Time of India

time4 hours ago

  • Time of India

Can you take antibiotics for COVID? WHO updates its guidelines on antibiotic usage for patients

As COVID-19 continues to evolve, so do the guidelines for how to tackle and treat it. Although the pandemic has drawn to a close, various strains are still at play and are causing infection amongst communities. After the Nimbus strain, now the Stratus strain is surging in the US, causing soar throat and hoarseness in voice in patients. Although these strains aren't fatal, many people still wonder: Can you take antibiotics for COVID? The answer, finally, is here. The latest guideline In a major update to its clinical guidelines, the World Health Organization (WHO) has advised against giving antibiotics to COVID-19 patients, even those with severe illness, if there's no clear sign of a bacterial infection. This shift in guidance comes after a new meta-analysis of studies showed that antibiotics do not improve outcomes in COVID-19 patients who don't have a bacterial infection. Overusing antibiotics without need, the WHO warns, could worsen the global problem of antimicrobial resistance. 'For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics,' the WHO said in its latest guidance. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Kate Middleton's Daring Outfit Took Prince William's Breath Away Crowdy Fan Undo 'For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics.' What are antibiotics? Antibiotics are medicines used to treat bacterial infections, not viral infections like COVID-19. They work by killing bacteria or stopping them from growing. Common illnesses treated with antibiotics include strep throat, urinary tract infections, and some types of pneumonia. COVID-19, however, is caused by the SARS-CoV-2 virus, not a bacterium. This means antibiotics do not treat the virus itself. Taking them unnecessarily won't help you recover faster, and it can cause serious side effects or even long-term health problems. Why the change? Since the beginning of the pandemic in 2020, both COVID-19 and the world's response to it have changed dramatically, the WHO noted. With lower infection rates, milder disease, and the removal of emergency public health measures, COVID-19 is now treated more like other illnesses in many countries. 'Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity,' the WHO said. 'Care for patients with COVID-19 has become more integrated with usual healthcare systems.' These changes prompted the WHO to review and revise all of its existing COVID-related recommendations. As a result, the new guidelines remove outdated advice or recommendations that are now considered basic medical practice and not specific to COVID-19. Recommendation backed by new research The updated antibiotic recommendations are based on the latest data from a systematic review and meta-analysis. These studies looked at how patients fared when treated with antibiotics during COVID-19, and whether those treatments were really necessary in the absence of a bacterial infection. At the same time, there's growing urgency to tackle antimicrobial resistance, a serious global threat where overuse of antibiotics makes bacteria resistant to treatment. The WHO stressed that these new guidelines are aimed at everyone involved in COVID-19 care, from doctors and nurses to hospital administrators and health system planners. COVID-19: Still a threat, and ever-evolving While vaccines, treatments, and previous infections have helped many people build immunity, COVID-19 hasn't disappeared. The SARS-CoV-2 virus continues to infect thousands of people daily, causing avoidable sickness and death. 'The virus continues to evolve in terms of infectivity, immune escape, and disease severity,' the WHO warned. Even though many countries are no longer in emergency mode, COVID-19 still requires careful clinical management, especially for high-risk populations. The new WHO guideline aims to reflect this shifting landscape, balancing new scientific evidence with the current global health context. 'This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19,' the WHO added. To sum it up… Antibiotics should not be used in COVID-19 patients unless there is a strong suspicion of a bacterial infection. This applies to both mild and severe cases. The guidance is part of a broader update reflecting new evidence and a changing pandemic. Overuse of antibiotics can worsen antimicrobial resistance, a growing health threat worldwide. The new guidelines apply to all levels of the health system involved in COVID-19 care. Study finds antiseptic drug is as good as antibiotics for preventing recurrent Urinary Tract Infections

Days after Jalandhar hospital deaths, Punjab govt to hire service providers to manage oxygen plants
Days after Jalandhar hospital deaths, Punjab govt to hire service providers to manage oxygen plants

Hindustan Times

time7 hours ago

  • Hindustan Times

Days after Jalandhar hospital deaths, Punjab govt to hire service providers to manage oxygen plants

Days after three deaths in Jalandhar civil hospital's ICU due to oxygen supply disruption, the department of health and family welfare is set to hire service providers for maintenance and management of biomedical installations, mainly oxygen plants, in the government health facilities across the per comprehensive annual maintenance service contract, the service providers will look after maintenance, management and operations of pressure swing adsorption (PSA) plants, liquid medical oxygen (LMO) tanks and medical gas pipeline systems (MGPS) including medical gas manifold, generator assembly, zeolite, electric panel and other ancillary items. Punjab health minister Dr Balbir Singh The department has already floated tenders for this, proposing a maintenance contract for three years, extendable by an additional two years, for 38 PSA plants and 33 MGPS units installed in government hospitals and medical colleges. Punjab health minister Dr Balbir Singh said the decision of hiring service providers has been taken to avoid Jalandhar hospital-like incidents in future. 'The service providers will ensure complete repair and maintenance of these units on regular basis besides maintaining complete record of repair, ensuring any sort of replacement, preventive maintenance on quarterly basis and calibration of machines,' the minister said. Dr Balbir added that the service provider shall ensure the availability of information, education & communication (IEC) standard operating procedure, checklist and log book related to operation, maintenance and safety of PSA and MGPS including manifold. 'Under this, the services engineers will be provided for rectification of complaints, besides ensuring regular testing and quality check,' he said. The minister added that the maintenance cost of PSA plants, installed during Covid under PM Care scheme, is very high and it is not financially feasible for its maintenance at hospital level. 'Due to the high maintenance cost of PSA plants, which produce medical-grade oxygen on the hospital premises, the department will ensure that LMO tanks and MGPS plants are fully operational in the government health facilities,' he said. On July 27, three patients, including a 15-year-old snake-bite victim, a 32-year-old drug overdose patient and a 30-year-old lung disease patient, died between 7.15 pm and 7.50 pm due to insufficient oxygen supply. Acting on the report of a probe team that pointed to gross negligence, the health department had suspended medical superintendent Dr Raj Kumar, senior medical officer Dr Surjit Singh and consultant anaesthesiologist Dr Sunakshi, while the services of Dr Shaminder Singh, the house surgeon, and technician Narinder Singh were terminated with immediate effect. The probe team found that instead of a technician overseeing the plant, a contractual ward attendant — a non-technical employee — was on duty when a malfunction in the plant caused the disruption of supply. He was ill-equipped to deal with the exigency, leading to the death of the three critically ill patients in the trauma centre.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store